| Christopher B Ingham Ii, CRNA | |
|
507 S Garfield St, Enid, OK 73703-5512 | |
| (580) 308-0820 | |
| Not Available |
| Full Name | Christopher B Ingham Ii |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 507 S Garfield St, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730248980 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergenchealth Pllc | 1355606641 | 585 |
News Archive
Despite one in 10 people worldwide having chronic kidney disease, a new global report - The Global Kidney Health Atlas - presented at this week's World Congress of Nephrology in Mexico City and compiled by the International Society of Nephrology and kidney health experts worldwide and published in JAMA- highlights the huge gaps in kidney disease care and prevention in both developed and developing countries, with many countries not prioritising kidney health.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
A study published Feb. 13 in Cell provides an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."
› Verified 2 days ago
| Entity Name | Enid Surgical Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134416373 PECOS PAC ID: 6002082567 Enrollment ID: O20120104000608 |
News Archive
Despite one in 10 people worldwide having chronic kidney disease, a new global report - The Global Kidney Health Atlas - presented at this week's World Congress of Nephrology in Mexico City and compiled by the International Society of Nephrology and kidney health experts worldwide and published in JAMA- highlights the huge gaps in kidney disease care and prevention in both developed and developing countries, with many countries not prioritising kidney health.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
A study published Feb. 13 in Cell provides an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."
› Verified 2 days ago
| Entity Name | Purple Martin Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902234057 PECOS PAC ID: 4486882834 Enrollment ID: O20140111000001 |
News Archive
Despite one in 10 people worldwide having chronic kidney disease, a new global report - The Global Kidney Health Atlas - presented at this week's World Congress of Nephrology in Mexico City and compiled by the International Society of Nephrology and kidney health experts worldwide and published in JAMA- highlights the huge gaps in kidney disease care and prevention in both developed and developing countries, with many countries not prioritising kidney health.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
A study published Feb. 13 in Cell provides an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."
› Verified 2 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20190618003098 |
News Archive
Despite one in 10 people worldwide having chronic kidney disease, a new global report - The Global Kidney Health Atlas - presented at this week's World Congress of Nephrology in Mexico City and compiled by the International Society of Nephrology and kidney health experts worldwide and published in JAMA- highlights the huge gaps in kidney disease care and prevention in both developed and developing countries, with many countries not prioritising kidney health.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
A study published Feb. 13 in Cell provides an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher B Ingham Ii, CRNA Po Box 960199, Oklahoma City, OK 73196-0001 Ph: (580) 548-1367 | Christopher B Ingham Ii, CRNA 507 S Garfield St, Enid, OK 73703-5512 Ph: (580) 308-0820 |
News Archive
Despite one in 10 people worldwide having chronic kidney disease, a new global report - The Global Kidney Health Atlas - presented at this week's World Congress of Nephrology in Mexico City and compiled by the International Society of Nephrology and kidney health experts worldwide and published in JAMA- highlights the huge gaps in kidney disease care and prevention in both developed and developing countries, with many countries not prioritising kidney health.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
A study published Feb. 13 in Cell provides an unprecedented look at the dozens of molecular steps that occur to bring about endometrial cancer, commonly known as uterine cancer.
According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."
› Verified 2 days ago
Paul Waddell Hutson, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 600 S Monroe St, Enid, OK 73701 Phone: 580-233-2300 | |
James Ketterman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 305 S 5th St, Enid, OK 73701 Phone: 580-233-6100 | |
Shelly Alvarado, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3906 Twilight Ave, Enid, OK 73703 Phone: 580-554-4725 | |
Ronald Charles Howe, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 600 S Monroe St, Enid, OK 73701 Phone: 580-233-2300 | |
Mr. Dale Kenneth Denton Jr., CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 205 W Maple Ave, Suite 301, Enid, OK 73701 Phone: 580-548-1106 Fax: 580-233-8802 |